Clinical trial

Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

NCT07154810

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-03-16

PhaseN/A

Study timeline

Study start (actual)2023-03-16Date precision: day

Registry last updated2025-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Cataractunresolved

Ocular Hypertensionunresolved

Interventions

Sponsors & collaborators

SpyGlass Pharma, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07154810 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.